News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Think AI is still out of reach for most clinicians? A new NCI study examines the feasibility of bringing AI to the clinic, using a publicly available platform and an AI-assisted model for detecting prostate cancer on MRI scans.

What’s the best role for AI in screening for breast cancer? This study, partially funded by NCI, helps define that role by looking at how well AI performed in finding hard-to-detect cancers.

Want to use your data science skills to find better cancer treatments? See how these NCI-funded researchers working with artificial intelligence (AI) used information from a survival model to refine treatment for glioblastoma.

A new spatial transcriptomics tool, called Spotiphy, can help you visualize gene distribution patterns across entire tissue sections, giving you a more complete picture of the tumor and its microenvironment.

See how a new AI-driven tool can help you measure micronuclei and similar structures to study their underlying biology, enabling you to more efficiently measure and characterize these tiny structures.

See how NCI-funded researchers built on previous studies to create a new model (called SMuRF) for head and neck cancer. Their model offers a new, more human-like, perspective to assessing head and neck cancer.

Read about a new collaboration between NCI and a company that develops AI-powered solutions for cancer diagnostics and therapeutics. NCI will be applying these tools to help advance research into personalized treatment for patients with cancer.

Thanks to this NCI-funded study, you now have a host of top-performing predictive models, data types, and training algorithms to help you better classify your patient samples.

Do you work with fusion oncoproteins? Explore a new protein language model (pLM) that NCI-funded researchers trained on fusion oncoproteins to advance discoveries in fusion-driven cancers!

Thanks to a new AI model called “SCORPIO,” you may someday be able to use a simple blood test and routine clinical information to decide which patients will benefit from immunotherapy.